Rüsselsheim, Germany

Dietrich Hadler

This inventor holds 1 USPTO granted patent. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dietrich Hadler. Retrieved from https://idiyas.com/inventor/dietrich-hadler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dietrich Hadler: Innovator in Pharmaceutical Composition for Dementia Treatment

Introduction

Dietrich Hadler is a notable inventor based in Rüsselsheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of dementia. His innovative work has the potential to impact the lives of many individuals affected by this condition.

Latest Patents

Dietrich Hadler holds a patent for a pharmaceutical composition aimed at the treatment of dementia. This composition comprises idebenone, which is useful for preventing the progression of dementia. His patent represents a crucial step forward in addressing the challenges associated with this debilitating disease.

Career Highlights

Hadler is associated with Takeda Chemical Industries, Inc., a leading company in the pharmaceutical sector. His work at Takeda has allowed him to focus on developing effective treatments that can improve patient outcomes. With a total of 1 patent, he has demonstrated his commitment to innovation in healthcare.

Collaborations

Throughout his career, Dietrich Hadler has collaborated with esteemed colleagues such as Shuji Higuchi and Akinobu Nagaoka. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.

Conclusion

Dietrich Hadler's contributions to the field of pharmaceuticals, particularly in dementia treatment, highlight his role as an innovator. His work continues to pave the way for future advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…